Skip to main
DD

DD Stock Forecast & Price Target

DD Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 18%
Buy 55%
Hold 27%
Sell 0%
Strong Sell 0%

Bulls say

DuPont de Nemours's positive outlook is supported by strong organic sales growth in its Healthcare & Water segments, driven by robust demand for medical packaging, biopharma, reverse osmosis, and ion exchange products. The company's strategic shift towards new products, with a vitality index improvement target from 35% to 45%, is expected to enhance pricing and sales mix, further bolstering revenue streams. Additionally, the Electronics & Industrial segment is poised for volume growth fueled by advancements in 5G technology, the Internet of Things, and increased technological investments, thereby positioning DuPont favorably in a competitive market landscape.

Bears say

DuPont de Nemours faces significant challenges due to anticipated delays in synergy realization stemming from the 2019 merger, which could hinder the company's ability to enhance profitability. Furthermore, ongoing weakness in the electronics and construction markets is likely to negatively impact revenue generation from critical segments of its diversified portfolio. Additionally, a slower-than-expected recovery in China further complicates the outlook, potentially leading to persistent underperformance in key business areas that are crucial for DuPont's financial health.

DD has been analyzed by 11 analysts, with a consensus rating of Buy. 18% of analysts recommend a Strong Buy, 55% recommend Buy, 27% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DuPont de Nemours and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DuPont de Nemours (DD) Forecast

Analysts have given DD a Buy based on their latest research and market trends.

According to 11 analysts, DD has a Buy consensus rating as of Jan 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $63.64, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $63.64, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DuPont de Nemours (DD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.